A comparative study of efficacy and safety of montelukast versus acebrophylline as add-on therapy to inhaled corticosteroids in bronchial asthma.

This article compares the effectiveness and safety of two medications, montelukast and acebrophylline, as additional treatments for bronchial asthma. The study found that montelukast was more effective than acebrophylline in improving lung function at 6 and 12 weeks. Both medications significantly improved asthma control at 12 weeks. No significant side effects were observed in either group. The study concludes that montelukast, when used with low-dose inhaled corticosteroids, was more effective than acebrophylline in managing bronchial asthma. [Extracted from the article]